Captrust Financial Advisors Purchases Shares of 49,567 Clover Health Investments, Corp. (NASDAQ:CLOV)

Captrust Financial Advisors purchased a new stake in shares of Clover Health Investments, Corp. (NASDAQ:CLOV) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 49,567 shares of the company’s stock, valued at approximately $156,000.

Several other institutional investors have also added to or reduced their stakes in the business. Vanguard Group Inc. boosted its holdings in shares of Clover Health Investments by 2.0% during the fourth quarter. Vanguard Group Inc. now owns 19,585,213 shares of the company’s stock worth $61,693,000 after purchasing an additional 386,499 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Clover Health Investments by 1.1% during the fourth quarter. Geode Capital Management LLC now owns 4,882,461 shares of the company’s stock worth $15,387,000 after purchasing an additional 53,760 shares during the period. Marshall Wace LLP boosted its holdings in shares of Clover Health Investments by 167.6% during the fourth quarter. Marshall Wace LLP now owns 3,769,765 shares of the company’s stock worth $11,875,000 after purchasing an additional 2,360,902 shares during the period. Northern Trust Corp boosted its holdings in shares of Clover Health Investments by 16.0% during the fourth quarter. Northern Trust Corp now owns 1,085,626 shares of the company’s stock worth $3,420,000 after purchasing an additional 149,714 shares during the period. Finally, Teacher Retirement System of Texas purchased a new stake in shares of Clover Health Investments during the fourth quarter worth about $2,769,000. 19.77% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Carladenise Armbrister Edwards sold 200,000 shares of Clover Health Investments stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $3.61, for a total transaction of $722,000.00. Following the completion of the transaction, the director now directly owns 273,227 shares in the company, valued at approximately $986,349.47. This trade represents a 42.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, General Counsel Karen Soares sold 52,500 shares of Clover Health Investments stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $3.80, for a total transaction of $199,500.00. Following the transaction, the general counsel now owns 1,299,663 shares of the company’s stock, valued at $4,938,719.40. The trade was a 3.88% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 327,500 shares of company stock worth $1,197,500 over the last three months. Company insiders own 22.28% of the company’s stock.

Analyst Ratings Changes

Separately, Canaccord Genuity Group increased their target price on shares of Clover Health Investments from $4.20 to $4.50 and gave the stock a “buy” rating in a report on Monday, March 3rd.

Clover Health Investments Trading Down 6.8%

Clover Health Investments stock opened at $3.28 on Friday. Clover Health Investments, Corp. has a 1-year low of $0.90 and a 1-year high of $4.87. The firm has a 50-day moving average of $3.54 and a 200-day moving average of $3.68. The firm has a market cap of $1.67 billion, a P/E ratio of -16.40 and a beta of 1.99.

Clover Health Investments (NASDAQ:CLOV) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of ($0.07) by $0.12. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. The business had revenue of $462.33 million during the quarter, compared to analyst estimates of $466.93 million. Research analysts forecast that Clover Health Investments, Corp. will post -0.12 earnings per share for the current fiscal year.

Clover Health Investments Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.